153 related articles for article (PubMed ID: 33341360)
1. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
Kanwar MK; Khush KK; Pinney S; Sherman C; Hall S; Teuteberg J; Uriel N; Kobashigawa J
J Heart Lung Transplant; 2021 Feb; 40(2):101-107. PubMed ID: 33341360
[TBL] [Abstract][Full Text] [Related]
2. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study.
Kamath M; Shekhtman G; Grogan T; Hickey MJ; Silacheva I; Shah KS; Shah KS; Hairapetian A; Gonzalez D; Godoy G; Reed EF; Elashoff D; Bondar G; Deng MC
Front Immunol; 2022; 13():825108. PubMed ID: 35251005
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling scores in dual organ transplant patients are similar to those in heart-only recipients.
Carey SA; Tecson KM; Jamil AK; Felius J; Wolf-Doty TK; Hall SA
Transpl Immunol; 2018 Aug; 49():28-32. PubMed ID: 29588161
[TBL] [Abstract][Full Text] [Related]
4. Correlation of gene expression profiling score, cardiac hemodynamics and echocardiographic parameters in asymptomatic, rejection-free pediatric heart transplant recipients.
Das BB; Chan KC; Winchester RW; Zakrzewski M; Niu J
Pediatr Transplant; 2020 May; 24(3):e13673. PubMed ID: 32067334
[TBL] [Abstract][Full Text] [Related]
5. Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.
Moayedi Y; Foroutan F; Miller RJH; Fan CS; Posada JGD; Alhussein M; Tremblay-Gravel M; Oro G; Luikart HI; Yee J; Shullo MA; Khush KK; Ross HJ; Teuteberg JJ
J Heart Lung Transplant; 2019 Jan; 38(1):51-58. PubMed ID: 30352779
[TBL] [Abstract][Full Text] [Related]
6. Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.
Indolfi G; Heaton N; Smith M; Mieli-Vergani G; Zuckerman M
Clin Transplant; 2012; 26(1):E55-61. PubMed ID: 21981027
[TBL] [Abstract][Full Text] [Related]
7. The impact of active cytomegalovirus infection on donor-derived cell-free DNA testing in heart transplant recipients.
Alam AH; Van Zyl J; Shakoor HI; Farsakh D; Abdelrehim AB; Maliakkal N; Jamil AK; Patel R; Felius J; McKean S; Hall SA
Clin Transplant; 2024 Mar; 38(3):e15287. PubMed ID: 38477177
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
[TBL] [Abstract][Full Text] [Related]
9. Heart transplant Recipients' perspectives on invasive versus Non-invasive graft failure surveillance Methods.
Jamil AK; Tecson KM; Ganz TT; Blankenship S; Felius J; Carey SA; Hall SA
Heart Lung; 2023; 57():41-44. PubMed ID: 36027738
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus and acute rejection after heart transplantation are not directly associated.
Boriskin YS; Booth JC; Corbishley CM; Madden BP; McKenna WJ; Murday AJ; Steel HM
J Med Virol; 1996 Sep; 50(1):59-70. PubMed ID: 8890042
[TBL] [Abstract][Full Text] [Related]
12. Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients.
Ahn R; Schaenman J; Qian Z; Pickering H; Groysberg V; Rossetti M; Llamas M; Hoffmann A; Gjertson D; Deng M; Bunnapradist S; Reed EF;
Front Immunol; 2021; 12():750659. PubMed ID: 34867983
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Different Valgancyclovir Formulations in the Universal 6-Month Prophylaxis Against CMV Infection in Renal Transplant Recipients: A Randomized Single-Centre Study.
Basic-Jukic N; Furic-Cunko V; Hudolin T; Zimak Z; Kirincich J; Kastelan Z
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Dec; 40(3):47-55. PubMed ID: 32109215
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.
Kidd IM; Clark DA; Sabin CA; Andrew D; Hassan-Walker AF; Sweny P; Griffiths PD; Emery VC
Transplantation; 2000 Jun; 69(11):2400-4. PubMed ID: 10868648
[TBL] [Abstract][Full Text] [Related]
15. Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.
Sun HY; Cacciarelli TV; Wagener MM; Singh N
Transpl Immunol; 2010 Aug; 23(4):166-9. PubMed ID: 20609386
[TBL] [Abstract][Full Text] [Related]
16. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.
Grossi P; Minoli L; Percivalle E; Irish W; Vigano M; Gerna G
Transplantation; 1995 Mar; 59(6):847-51. PubMed ID: 7701579
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and allograft rejection among pediatric heart transplant recipients in the era of valganciclovir prophylaxis.
Das BB; Prusty BK; Niu J; Sue PK
Pediatr Transplant; 2020 Dec; 24(8):e13750. PubMed ID: 32573886
[TBL] [Abstract][Full Text] [Related]
19. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
